Skip to main content

Advertisement

Table 6 NSCLC patients (stage I, II and III) with surgical resection in the Pre-EBUS cohort compared to the Post-EBUS cohort

From: Impact of the introduction of EBUS on time to management decision, complications, and invasive modalities used to diagnose and stage lung cancer: a pragmatic pre-post study

  Pre-EBUS cohort (n = 97) Post-EBUS cohort (n = 153)  
NSCLC stage Surgery n (%) No surgery n (%) Surgery n (%) No surgery n (%) p
I 16 (59.3) 11 (40.7) 36 (65.5) 19 (34.5) 0.378a
II 2 (16.7) 10 (83.3) 13 (56.5) 10 (43.5) 0.026a,*
III 5 (8.6) 53 (91.4) 3 (4.0) 72 (96.0) 0.228b
Total 23 (23.7) 74 (76.3) 52 (34) 101 (66)  
  1. *p < 0.05
  2. aPearson’s chi squared test
  3. bFisher’s exact test